RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.969
EU - Europa 5.271
AS - Asia 3.696
SA - Sud America 437
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
Totale 20.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.854
GB - Regno Unito 1.808
CN - Cina 1.209
IT - Italia 1.018
SG - Singapore 1.005
HK - Hong Kong 692
SE - Svezia 629
DE - Germania 403
BR - Brasile 359
NL - Olanda 289
RU - Federazione Russa 265
UA - Ucraina 221
FI - Finlandia 199
VN - Vietnam 197
TR - Turchia 184
FR - Francia 138
BG - Bulgaria 90
IN - India 87
KR - Corea 75
CA - Canada 69
ID - Indonesia 59
BE - Belgio 37
CZ - Repubblica Ceca 31
AR - Argentina 27
JP - Giappone 26
BD - Bangladesh 25
IR - Iran 23
MX - Messico 22
ES - Italia 20
PL - Polonia 20
AT - Austria 18
IE - Irlanda 18
LT - Lituania 18
ZA - Sudafrica 18
IQ - Iraq 17
BZ - Belize 15
AE - Emirati Arabi Uniti 11
EU - Europa 11
MY - Malesia 11
UZ - Uzbekistan 11
EC - Ecuador 10
PY - Paraguay 9
CL - Cile 8
MA - Marocco 8
RO - Romania 8
VE - Venezuela 8
CH - Svizzera 7
EG - Egitto 7
PK - Pakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AZ - Azerbaigian 6
GR - Grecia 5
IL - Israele 5
TW - Taiwan 5
BO - Bolivia 4
CO - Colombia 4
CY - Cipro 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
RS - Serbia 4
TN - Tunisia 4
AU - Australia 3
DK - Danimarca 3
NP - Nepal 3
PA - Panama 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BH - Bahrain 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AM - Armenia 1
CG - Congo 1
DZ - Algeria 1
EE - Estonia 1
GN - Guinea 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 20.433
Salva come PNG Salva come JPEG
Città #
Southend 1.357
Fairfield 1.240
Ashburn 1.055
Santa Clara 1.006
Woodbridge 804
Hong Kong 688
Singapore 643
Chandler 636
Houston 582
Ann Arbor 507
Seattle 477
Jacksonville 425
Wilmington 424
Dearborn 423
Cambridge 389
Nyköping 350
Hefei 331
Beijing 244
Amsterdam 242
London 225
Modena 198
New York 175
Los Angeles 150
Chicago 124
Izmir 104
San Diego 102
Helsinki 96
Munich 93
Princeton 87
Sofia 87
Eugene 82
Fremont 75
Moscow 72
Seoul 72
Buffalo 71
Milan 66
Ho Chi Minh City 64
Council Bluffs 61
Bremen 55
Shanghai 51
The Dalles 46
Jakarta 44
Rome 44
Dallas 41
Des Moines 40
Hanoi 39
Salt Lake City 36
Boardman 35
Brussels 33
Columbus 32
Redwood City 31
São Paulo 31
Bologna 30
Ottawa 28
San Jose 27
Turku 24
Tokyo 23
Toronto 20
Washington 18
Elk Grove Village 17
Las Vegas 17
Orem 17
San Francisco 17
Paris 16
Stockholm 16
Tampa 16
Atlanta 15
Belize City 15
Dublin 15
Guangzhou 15
Naples 15
Philadelphia 15
Warsaw 15
Frankfurt am Main 14
Kunming 14
Montreal 14
Albuquerque 13
Brooklyn 13
Chennai 13
Nanjing 13
Reggio Emilia 13
Boston 12
Chiswick 12
Da Nang 12
Dong Ket 12
Lancaster 12
Norwalk 12
Tulare 12
Vienna 12
Denver 11
Rio de Janeiro 11
Changsha 10
Johannesburg 10
Kent 10
Palermo 10
Romainville 10
Saint Louis 10
Sterling 10
Tashkent 10
Brno 9
Totale 15.090
Salva come PNG Salva come JPEG
Nome #
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 406
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 356
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 341
B cells and herpesviruses: a model of lymphoproliferation 331
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 330
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 324
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 322
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 318
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 316
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 313
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 310
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 307
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 305
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 302
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 298
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 296
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 291
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 291
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 290
Mucorales-specific T cells in patients with hematologic malignancies 284
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 282
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 282
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 281
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 279
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 277
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 275
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 274
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 271
Parvoviruses in blood donors and transplant patients, Italy 271
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 266
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 265
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 262
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 257
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 257
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 257
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 256
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 255
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 253
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 252
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 249
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 249
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 240
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 238
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 237
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 237
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 230
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 229
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 228
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 227
How I treat HHV8/KSHV-related diseases in posttransplant patients. 224
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 223
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 222
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 221
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 218
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 217
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 216
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 211
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 210
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 207
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 207
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 205
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 204
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 198
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 197
Pneumonia in acute leukaemia:blossoming culprits 195
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 192
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 188
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 187
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 182
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 175
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 172
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 164
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 162
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 161
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 160
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 158
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 156
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 151
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 150
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 147
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 146
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 134
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 122
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 121
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 117
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 116
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 94
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 84
The dynamic functions of IRF4 in B cell malignancies 70
Totale 20.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.270 0 0 0 0 0 133 154 276 114 318 141 134
2021/20221.747 67 228 221 98 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20253.847 155 49 76 279 701 541 309 231 431 151 385 539
2025/20263.297 611 367 609 647 969 94 0 0 0 0 0 0
Totale 20.651